Medical News

RSS

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).

29 Jun 2011

Texas passes health program revamp; Oregon House acts to create better coordinated care

The Legislature approved and sent to the governor Monday a health care savings bill under which Texas could seek permission to redesign entirely the Medicaid and Medicare programs, and abortion-rights opponents scored several victories in the measure (Garrett, 6/27).

29 Jun 2011

Researchers discover herpes virus-associated disease in monkeys

Researchers at Oregon Health & Science University have discovered a naturally occurring disease in monkeys that is very much like multiple sclerosis in humans - a discovery that could have a major impact on efforts to understand the cause of multiple sclerosis.

29 Jun 2011

Medivir, Meda renegotiate agreement for cold sores medicine, Xerese

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has renegotiated the terms of its commercial partnership with Meda for Xerese, its unique marketed product for cold sores (herpes labialis).

29 Jun 2011

Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for children

A cellulose powder has been used increasingly for many years against allergic rhinitis. Still, there has been a shortage of scientific evidence for its efficacy in seasonal allergic rhinitis (hay fever), particularly in children. Now, however, scientists from the Sahlgrenska Academy and the Department of Plant and Environmental Sciences at the University of Gothenburg have proven that the cellulose powder reduces symptoms of seasonal allergic rhinitis in children, without any adverse effects.

29 Jun 2011

Experienced North Korean aid worker says hunger crisis imminent

North Korea has significantly cut public food aid and could be heading toward a hunger crisis, said Katharina Zellweger, head of a Swiss Agency for Development and Cooperation's office in Pyongyang and "one of the most experience aid workers" in the country, according to Agence France-Presse.

29 Jun 2011

Nuvilex to continue development of acquired live-cell encapsulation technology

Nuvilex, Inc. announced its plans to continue development of the live-cell encapsulation technology obtained with its recent acquisition of SG Austria, to carry out the pancreatic cancer clinical trial, to maintain and expand customers utilizing the encapsulation technology, and to establish itself as an active participant in the stem cell arena. The stem cell market was estimated to be $21.5 billion globally in 2010 and is forecast to reach $63.8 billion by 2015.

29 Jun 2011

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD).

29 Jun 2011

G20 agriculture summit communique suggests action is missing

"The G20 agriculture ministers seem to agree: they're all for food security, as long as it doesn't cost anything," according to a post on the Center for Global Development's "Rethinking U.S. Foreign Assistance Blog."

29 Jun 2011

Asperger syndrome characteristics evident during child's first two years

People with Asperger syndrome have problems with social interaction and attentiveness, and are also sensitive to noise and light. Several of these characteristics were evident to parents during their child's first two years, reveals Petra Dewrang's thesis in psychology at the University of Gothenburg.

29 Jun 2011

Cotton swab dramatically reduces infections in post-operative incision sites

A simple item found in almost every medicine cabinet - a cotton swab -- may be a key tool in the fight against post-surgical wound infections.

29 Jun 2011

Annual per person health care spending hit $8,100 in 2009

National health care spending rose 23 percent between 2005 and 2009, according to a report by the National Institute for Health Care Management Foundation.

29 Jun 2011

GABA corrects both known causes of Type 1 diabetes

A chemical produced by the same cells that make insulin in the pancreas prevented and even reversed Type 1 diabetes in mice, researchers at St. Michael's Hospital have found.

29 Jun 2011

New concepts for how evolutionary change occurs

At a recent Kavli Futures Symposium, 19 experts from a diverse range of fields discussed the promise of using the lab to understand and exploit the evolution of organisms -- progress that may one day lead to new vaccines or other biotechnology products.

29 Jun 2011

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today released data showing that its gene therapy Glybera® (alipogene tiparvovec) significantly reduces the risk of pancreatitis in patients with Lipoprotein Lipase Deficiency (LPLD). Pancreatitis, or inflammation of the pancreas, is a major clinical symptom of LPLD.

29 Jun 2011

Direct incentives for vaccination would increase rates

In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.

29 Jun 2011

Physical activity can positively affect cells in intervertebral discs

Physical exercise has a positive effect on the formation of cells in the intervertebral discs. This is shown by a study from the Sahlgrenska Academy, University of Gothenburg, presented at the annual meeting of the International Society for the Study of the Lumbar Spine (ISSLS), which is currently taking place in Gothenburg.

29 Jun 2011

Bristol-Myers Squibb and Mylan expand access to HIV drug Reyataz in sub-Saharan Africa and India

Bristol-Myers Squibb Company today announced a new agreement to expand access to Reyataz (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Limited, a Mylan Company, enables the generic company to manufacture and sell atazanavir, as well as stavudine and didanosine, in sub-Saharan Africa and India.

29 Jun 2011

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..

29 Jun 2011

Christie poised to sign bill that will increase costs of benefits for state employees

The New Jersey state Senate on Monday approved the bill, which will raise pension and health benefit expenses for more than 500,000 state workers. Meanwhile, in Illinois, Gov. Pat Quinn will sign today a measure to overhaul the state's workers' compensation system.

29 Jun 2011

Medical News

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Texas passes health program revamp; Oregon House acts to create better coordinated care

Researchers discover herpes virus-associated disease in monkeys

Medivir, Meda renegotiate agreement for cold sores medicine, Xerese

Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for children

Experienced North Korean aid worker says hunger crisis imminent

Nuvilex to continue development of acquired live-cell encapsulation technology

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

G20 agriculture summit communique suggests action is missing

Asperger syndrome characteristics evident during child's first two years

Cotton swab dramatically reduces infections in post-operative incision sites

Annual per person health care spending hit $8,100 in 2009

GABA corrects both known causes of Type 1 diabetes

New concepts for how evolutionary change occurs

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

Direct incentives for vaccination would increase rates

Physical activity can positively affect cells in intervertebral discs

Bristol-Myers Squibb and Mylan expand access to HIV drug Reyataz in sub-Saharan Africa and India

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

Christie poised to sign bill that will increase costs of benefits for state employees

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News